GVGiulio Vallati

Giulio Vallati

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Giulio Vallati has a total of 43 co-authors. Here are the top co-authors by number of shared publications:

  • Francesco Minisola

    Department of Urology, "Regina Elena" National Cancer Institute, Rome, Italy

    2 shared publications
  • Gabriele Tuderti

    Department of Urology, "Regina Elena" National Cancer Institute, Rome, Italy

    2 shared publications
  • Leonardo Misuraca

    Department of Urology, "Regina Elena" National Cancer Institute, Rome, Italy

    2 shared publications
  • Michele Gallucci

    Department of Urology, "Regina Elena" National Cancer Institute, Rome, Italy

    2 shared publications
  • Salvatore Guaglianone

    Department of Urology, "Regina Elena" National Cancer Institute, Rome, Italy

    2 shared publications
  • A. Caulo

    Università Cattolica del Sacro Cuore, Policlinico A. Gemelli

    1 shared publication

Latest Publications

  • Robotic Intracorporeal Padua Ileal Bladder: Surgical Technique, Perioperative, Oncologic and Functional Outcomes

    by Giuseppe Simone, Rocco Papalia, Leonardo Misuraca, Gabriele Tuderti, Francesco Minisola, Mariaconsiglia Ferriero, Giulio Vallati, Salvatore Guaglianone, Michele Gallucci


  • V12-07 ROBOTIC INTRACORPOREAL “PADUA ILEAL BLADDER”: SURGICAL TECHNIQUE, PERIOPERATIVE, ONCOLOGIC AND FUNCTIONAL OUTCOMES

    by Giuseppe Simone, Rocco Papalia, Leonardo Misuraca, Gabriele Tuderti, Francesco Minisola, Mariaconsiglia Ferriero, Giulio Vallati, Salvatore Guaglianone, Michele Gallucci

  • Impact of 3D Rotational Angiography on Liver Embolization Procedures: Review of Technique and Applications

    by Pierleone Lucatelli, Mario Corona, Renato Argirò, Michele Anzidei, Giulio Vallati, Fabrizio Fanelli, Mario Bezzi, Carlo Catalano

    In the last years, the interest into interventional applications of C-arm cone-beam CT (CBCT) progressively raised, widening its clinical application from the original field of interventional neuroradiology to the field of peripheral procedures. Liver embolization procedures, due to their complexity and potential treatment-related life-threatening complications, represent one of the main clinical applications of this novel angiographic technique. CBCT has been demonstrated to render procedures safer and technically easier, and to predict outcome as well as to avoid major complications in different treatment scenarios (trans-arterial embolization, trans-arterial chemoembolization, selective internal radiation therapy, percutaneous portal vein embolization). This review summarizes all technical, dosimetric and procedural aspects of CBCT techniques, underlying all its potential clinical advantages in the field of liver embolization procedures. Moreover, the paper provides all the instructions to obtain the best diagnostic performance out of this novel angiographic technique.


  • Open Access

    Dose evaluation for skin and organ in hepatocellular carcinoma during angiographic procedure

    by Daniela D’alessio, Claudia Giliberti, Antonella Soriani, Livio Carpanese, Giuseppe Pizzi, Giulio Eugenio Vallati, Lidia Strigari

    Purpose: The purpose of this study is to evaluate the radiation dose in patients undergoing liver angiographic procedure and verify the usefulness of different dose measurements to prevent deterministic effects. Gafchromic film, MicroMOSFET data and DIAMENTOR device of the X-ray system were used to characterize the examined interventional radiology (IR) procedure. Materials and methods: A liver embolization procedure, the SIRT (Selective Internal Radiation Therapy), was investigated. The exposure parameters from the DIAMENTOR as well as patient and geometrical data were registered. Entrance skin dose map obtained using Gafchromic film (ESDGAF) in a standard phantom as well as in 12 patients were used to calculate the maximum skin dose (MSDGAF). MicroMOSFETs were used to assess ESD in relevant points/areas. Moreover, the maximum value of five MicroMOSFETs array, due to the extension of treated area and to the relative distance of 2-3 cm of two adjacent MicroMOSFETs, was useful to predict the MSD without interfering with the clinical practice. PCXMC vers. 1.5 was used to calculate effective dose (E) and equivalent dose (H). Results: The mean dose-area product (DAP(DIAMENTOR)) for SIRT procedures was 166 Gycm(2), although a wide range was observed. The mean MSDGAF for SIRT procedures was 1090 mGy, although a wide range was experienced. A correlation was found between the MSDGAF measured on a patient and the DAPDIAMENTOR value for liver embolizations. MOSFET and Gafchromic data were in agreement within 5% in homogeneous area and within 20% in high dose gradient regions. The mean equivalent dose in critical organs was 89.8 mSv for kidneys, 22.9 mSv for pancreas, 20.2 mSv for small intestine and 21.0 mSv for spleen. Whereas the mean E was 3.7 mSv (range: 0.5-13.7). Conclusions: Gafchromic films result useful to study patient exposure and determine localization and amplitude of high dose skin areas to better predict the skin injuries. Then, DAPDIAMENTOR or MOSFET data could offer real-time methods, as on-line dose alert, to avoid any side effects during liver embolization with prolonged duration.


  • Neoadjuvant Gemox Followed by Gem-Based Chemoradiation for Locally advanced Unresectable Pancreatic Cancer

    by V. Vaccaro, I. Sperduti, E. Bria, B. Saracino, M.S. Pino, G. Grazi, A. Gelibter, G. Vallati, F. Cognetti, M. Milella

  • Detection of noncalcified pulmonary nodules on low-dose MDCT: comparison of the sensitivity of two CAD systems by using a double reference standard

    by A. R. Larici, M. Amato, P. Ordóñez, F. Maggi, L. Menchini, A. Caulo, L. Calandriello, G. Vallati, S. Giunta, M. Crecco, et al.

    This study compared the sensitivity of two commercial computer-aided detection (CAD) systems in identifying noncalcified pulmonary nodules on low-dose multidetector computed tomography (MDCT) scans by using a double reference standard. Three chest low-dose MDCT scans of patients who had undergone lung cancer screening were retrospectively analysed using two distinct commercial CAD systems: LungCAD VC10A, Siemens Medical Solutions (CAD1) and LungVCAR, GE Healthcare (CAD2). The exact location of each finding suggested by each system was recorded by an independent reader according to spatial coordinates (x, y, z). Two panels of experienced thoracic radiologists from two different institutions independently established two reference standards (RS1, RS2) by identifying the true positive findings with spatial coordinates without using CAD. Sensitivity of the two CAD systems, defined by lesionlevel analysis, was tested and sensitivities compared. RS1 identified 34 noncalcified pulmonary nodules, whereas RS2 identified 54. The total number of findings detected by the two CAD systems was 684. CAD1 correctly identified 13/34 nodules (sensitivity 38%) for RS1 and 17/54 (sensitivity 30%) for RS2, whereas CAD2 correctly identified 11/34 nodules (sensitivity 35%) for RS1 and 13/54 (sensitivity 23%) for RS2. Comparison between the two CAD systems did not show a statistically significant difference in terms of sensitivity (pp=0.42) and RS2 (p=0.33). The two commercial CAD systems had similar sensitivity in detecting noncalcified pulmonary nodules on low-dose MDCT of the chest. Confrontare la sensibilità di due sistemi computer-aided detection (CAD) commerciali nell’identificazione di noduli polmonari non calcifici negli esami con tomografia computerizzata multidetettore (TCMD) a bassa dose, mediante l’impiego di un doppio standard di riferimento. Tre esami TCMD a bassa dose del torace di pazienti sottoposti a screening del tumore polmonare sono stati retrospettivamente analizzati mediante due diversi sistemi CAD disponibili in commercio (LungCAD VC10A, Siemens Medical Solutions; CAD1) (LungVCAR, GE Healthcare; CAD2). La posizione esatta secondo le coordinate spaziali (x, y, z) di ogni reperto identificato automaticamente da ciascuno dei due sistemi è stata registrata da un lettore indipendente. Due gruppi di radiologi toracici esperti, appartenenti a due diverse Istituzioni, hanno stabilito in modo indipendente i due rispettivi standard di riferimento (SR1, SR2), identificando i reperti veri positivi mediante coordinate spaziali, senza l’uso del CAD. è stata testata la sensibilità dei due sistemi CAD, definita per lesione (analisi per lesione), ed effettuato un confronto statistico tra i valori di sensibilità. SR1 ha identificato 34 noduli polmonari non calcifici, mentre SR2 ne ha identificati 54. Il numero totale di reperti segnalati dai due CAD è stato 684. Il CAD1 ha identificato correttamente 13/34 noduli (sensibilità 38%) indicati da SR1 e 17/54 (sensibilità 30%) indicati da SR2, mentre il CAD2 ha identificato 11/34 noduli (sensibilità 35%) indicati da SR1 e 13/54 (sensibilità 23%) indicati da SR2. Il confronto tra i due sistemi CAD non ha mostrato una differenza statisticamente significativa in termini di sensibilità (p<0,05) sia in rapporto a SR1 (p=0,42) che a SR2 (p=0,33). I due sistemi CAD commerciali hanno dimostrato una sensibilità sovrapponibile nell’identificazione dei noduli polmonari non calcifici in TCMD a bassa dose del torace.